Skip to main content

Response: Similar effect of quercetin on CYP2E1 and CYP2C9 activities in humans?

This is a preview of subscription content, access via your institution.

References

  1. Bedada SK, Neerati P (2018) The effect of quercetin on the pharmacokinetics of chlorzoxazone, a CYP2E1 substrate, in healthy subjects. Eur J Clin Pharmacol 74:91–97

    Article  PubMed  CAS  Google Scholar 

  2. Bedada SK, Neerati P (2018) Evaluation of the effect of quercetin treatment on CYP2C9 enzyme activity of diclofenac in healthy human volunteers. Phytother Res 32:305–311

    Article  PubMed  CAS  Google Scholar 

  3. Rajnarayana K, Venkatesham A, Nagulu M, Srinivas M, Krishna DR (2008) Influence of diosmin pretreatment on the pharmacokinetics of chlorzoxazone in healthy male volunteers. Drug Metabol Drug Interact 23:311–321

    PubMed  CAS  Google Scholar 

  4. Rajnarayana K, Venkatesham A, Krishna DR (2007) Bioavailability of diclofenac sodium after pretreatment with diosmin in healthy volunteers. Drug Metabol Drug Interact 22:165–174

    Article  PubMed  CAS  Google Scholar 

  5. Bedada SK, Neerati P (2016) Resveratrol pretreatment affects CYP2E1 activity of chlorzoxazone in healthy human volunteers. Phytother Res 30:463–468

    Article  PubMed  CAS  Google Scholar 

  6. Bedada SK, Yellu NR, Neerati P (2016) Effect of resveratrol treatment on the pharmacokinetics of diclofenac in healthy human volunteers. Phytother Res 30:397–401

    Article  PubMed  CAS  Google Scholar 

  7. Izzo AA, Ernst E (2009) Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs 69:1777–1798

    Article  PubMed  CAS  Google Scholar 

  8. Egert S, Wolffram S, Bosy-Westphal A, Boesch-Saadatmandi C, Wagner AE, Frank J, Rimbach G, Mueller MJ (2008) Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J Nutr 138:1615–1621

    Article  PubMed  CAS  Google Scholar 

  9. Gorski JC, Jones DR, Wrighton SA, Hall SD (1997) Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone. Xenobiotica 27:243–256

    Article  PubMed  CAS  Google Scholar 

  10. Carriere V, Goasduff T, Ratanasavanh D, Morel F, Gautier JC, Guillouzo A, Beaune P, Berthou F (1993) Both cytochromes P450 2E1 and 1A1 are involved in the metabolism of chlorzoxazone. Chem Res Toxicol 6:852–857

    Article  PubMed  CAS  Google Scholar 

  11. Ono S, Hatanaka T, Hotta H, Tsutsui M, Satoh T, Gonzalez FJ (1995) Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1. Pharmacogenetics 5:143–150

    Article  PubMed  CAS  Google Scholar 

  12. Eap CB, Schnyder C, Besson J, Savary L, Buclin T (1998) Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers. Clin Pharmacol Ther 64:52–57

    Article  PubMed  CAS  Google Scholar 

  13. Lucas D, Ferrara R, Gonzalez E, Bodenez P, Albores A, Manno M, Berthou F (1999) Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans. Pharmacogenetics 9:377–388

    Article  PubMed  CAS  Google Scholar 

  14. Yamazaki H, Guo Z, Guengerich FP (1995) Selectivity of cytochrome P4502E1 in chlorzoxazone 6-hydroxylation. Drug Metab Dispos 23:438–440

    PubMed  CAS  Google Scholar 

  15. Kharasch ED, Thummel KE, Mhyre J, Lillibridge JH (1993) Single-dose disulfiram inhibition of chlorzoxazone metabolism: a clinical probe for P450 2E1. Clin Pharmacol Ther 53:643–650

    Article  PubMed  CAS  Google Scholar 

  16. Leclercq I, Desager JP, Horsmans Y (1998) Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single ingestion of watercress. Clin Pharmacol Ther 64:144–149

    Article  PubMed  CAS  Google Scholar 

  17. Frye RF, Branch RA (2002) Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects. Br J Clin Pharmacol 53:155–162

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Loizou GD, Cocker J (2001) The effects of alcohol and diallyl sulphide on CYP2E1 activity in humans: a phenotyping study using chlorzoxazone. Hum ExpToxicol 20:321–327

    Article  CAS  Google Scholar 

  19. Zhang S, Yang X, Morris ME (2004) Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport. Mol Pharmacol 65:1208–1216

    Article  PubMed  CAS  Google Scholar 

  20. Alvarez AI, Real R, Pérez M, Mendoza G, Prieto JG, Merino G (2010) Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response. J Pharm Sci 99:598–617

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Satish Kumar Bedada.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Bedada, S.K., Neerati, P. Response: Similar effect of quercetin on CYP2E1 and CYP2C9 activities in humans?. Eur J Clin Pharmacol 74, 1189–1190 (2018). https://doi.org/10.1007/s00228-018-2481-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-018-2481-x